Home       Market Dynamics     Sector Analysis     Company Insights     AI Investing     Strategies     Contact Us     Login             

Alnylam Pharmaceuticals (ALNY) Stock Price Prediction and News Highlight
Tue. Apr 1, 2025

Alnylam Pharmaceuticals is at the forefront of innovation in RNAi therapeutics and gene therapy, particularly for conditions such as ATTR amyloidosis. The company's commitment to patient-centric drug development ensures that treatments reflect the needs and demographics of the patient population. Notably, advancements in siRNA therapeutics further highlight Alnylam's leadership in biotechnology. These themes underscore a strong trajectory towards effective and personalized medicine.

The price action of Alnylam Pharmaceuticals (ALNY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.7 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for ALNY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.9, and the negative at -0.2 on 2025-04-01. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (5.1) will drive up the price.

The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band.

ALNY
DateAttentionPricePrice
Level
ChangeSMA10
Trend
Trend
Sentiment
Hourly
Trend
Hourly
StdDev
Market
Sentiment
ActionPFund.News
Sentiment
2025-04-010%(0%)    0    0%    0.7          5.1    -1   
2025-03-310%(0%)    0    0%    0.8          5.5    -1   
2025-03-280%(0%)    0    0%    0.7          5.2    -1   
2025-03-270%(0%)    0    0%    0.7          5.2    -1   
2025-03-260%(0%)    0    0%    0.7          5.3    -1   
2025-03-250%(0%)    0    0%    0.7          4.9    -1   
2025-03-240%(0%)    0    0%    0.7          4.9    -1   
2025-03-210%(0%)    0    0%    0.7          4.9    -1   
2025-03-180%(0%)    0    0%    0.7          4.9    -1   
2025-03-170%(0%)    0    0%    0.7          5.2    -1   
 
Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position.
Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force.

2025-09-29 03:57:29 The focus on presentation and investor interaction may influence Alnylam's stock performance and public perception.
2025-09-29 03:57:29 The virtual format of the conference reflects ongoing trends in digital engagement in the healthcare industry.
2025-09-29 03:57:29 The webcast offers a platform for enhanced investor engagement and potential capital investment opportunities.
2025-09-29 03:57:29 Alnylam is recognized for its innovation in RNAi therapeutics, highlighting the company's role in advanced pharmaceutical development.
2025-09-29 03:57:29 The announcement of a presentation by Alnylam's management reflects strong leadership engagement with investors and stakeholders.


About   Contact Us  
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA